Cutaneous Adverse Events of Osimertinib in Diverse Patient Populations with EGFR-mutated Non-Small Cell Lung Cancer: A Retrospective Cohort Analysis

An additional Kaplan-Meier curve seen in supplemental Figure 1 was conducted to assess overall survival among groups with and without the development of a cutaneous treatment related adverse event; results showed similar survival among the groups (p=0.960).为评估发生与未发生皮肤治疗相关不良事件（cutaneous treatment-related adverse event）的两组人群的总生存期（overall survival），本研究对补充图1（Supplemental Figure 1）中展示的额外卡普兰-迈耶曲线（Kaplan-Meier curve）进行了分析；结果显示两组的总生存期相似（P=0.960）。